VIVUS Announces Date of Fourth Quarter and Year End 2014 Update and Financial Results Conference Call

VIVUS, Inc. (Nasdaq:VVUS) today announced that it will report financial results for the fourth quarter and year ended December 31, 2014 after the NASDAQ Market closes on Tuesday, February 24, 2015. The company will conduct a conference call and an audio webcast at 4:30 pm EST the same day.

Date: February 24, 2015 Time: 4:30 PM EST

Listen via Internet: http://ir.vivus.com/

Schedule this webcast into MS-Outlook calendar (click open when prompted): http://apps.shareholder.com/PNWOutlook/t.aspx?m=67953&k=64288A08

Toll-free: [phone] International: [phone]

A webcast replay will be available on the VIVUS website for 30 days.

VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. For more information about the company, please visit www.vivus.com.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS's Form 10-K for the year ended December 31, 2013 as filed on February 28, 2014 and as amended by the Form 10-K/A filed on April 30, 2014, and periodic reports filed with the Securities and Exchange Commission.

CONTACT: VIVUS, Inc.
         Dana B. Shinbaum (Corporate Development & Investor Relations)
         650-934-5200
         [e-mail]

         The Trout Group
         Brian Korb (Managing Director)
         646-378-2923
         [e-mail]